A detailed history of Beacon Capital Management, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Beacon Capital Management, LLC holds 60,314 shares of VXRT stock, worth $36,188. This represents 0.01% of its overall portfolio holdings.

Number of Shares
60,314
Previous 60,314 -0.0%
Holding current value
$36,188
Previous $40,000 27.5%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$0.53 - $1.3 $5,035 - $12,350
9,500 Added 18.7%
60,314 $40,000
Q4 2023

Jan 09, 2024

BUY
$0.57 - $0.85 $22,799 - $34,000
40,000 Added 369.89%
50,814 $28,000
Q3 2022

Oct 05, 2022

BUY
$2.09 - $4.5 $12,151 - $26,163
5,814 Added 116.28%
10,814 $38,000
Q1 2022

May 16, 2022

BUY
$4.29 - $6.64 $21,450 - $33,200
5,000 New
5,000 $25,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $75.9M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Beacon Capital Management, LLC Portfolio

Follow Beacon Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Capital Management, LLC with notifications on news.